In Brief: Lipoplasty device downclassification
This article was originally published in The Gray Sheet
Final rule downclassifying suction lipoplasty systems for use in aesthetic body contouring from Class III to Class II published in the Feb. 17 Federal Register. The reclassification becomes effective March 19. FDA announced its intention to downclassify suction lipoplasty systems in November 1996 ("The Gray Sheet" Nov. 18, 1996, I&W-2). The agency issued the downclassification proposal based on findings in support of a 1989 recommendation by FDA's General and Plastic Surgery Devices Panel to downclassify the devices. The American Society for Aesthetic Plastic Surgery filed a petition in December 1988 requesting the downclassification...
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.